News – Page 4

Johnson & Johnson Stops Selling Talc-Based Baby Powder in U.S.

Johnson & Johnson announced Tuesday that it will permanently discontinue its talc-based Johnson’s Baby Powder in the U.S. and Canada. The company cited…

Emily Miller May 20, 2020
DOJ, 3M Crack Down on COVID-19 Price Gouging

A New York man became the first person federally charged with hoarding and reselling tons of “COVID-19 essentials” at a huge markup,…

Michelle Llamas May 12, 2020
Talcum Powder & Ovarian Cancer Lawsuits: A Q&A with Trial Attorney Trent Miracle

Johnson & Johnson is facing more than 16,500 talcum powder lawsuits consolidated in a multidistrict litigation, or MDL, in New Jersey federal court,…

Michelle Llamas May 11, 2020
COVID-19-Related Class Action Lawsuits on the Rise

As COVID-19 case numbers climb across the United States, so do the numbers of class action lawsuits for consumer fraud, misleading…

Michelle Llamas April 29, 2020
Vetting a COVID-19 Drug: A Q&A with Immunologist Dr. Hooman Noorchashm

As the global count of COVID-19 cases continues to climb, researchers, scientists and drug makers are working quickly to find a potential treatment.

Michelle Llamas April 28, 2020
Chlorthalidone Linked to Higher Risk of Electrolyte, Kidney Problems

Chlorthalidone — known by the brand name Thalitone — is the American College of Cardiology and American Heart Association’s preferred first-line treatment…

Michelle Llamas April 20, 2020
Drug Makers Warned for Potential Diethylene Glycol Toxin Contamination

In January 2020, the U.S. Food and Drug Administration warned three pharmaceutical manufacturers for significant violations of current good manufacturing practices and…

Michelle Llamas April 20, 2020
Company Waited 2 Months After FDA Warning to Recall Rompe Pecho Cough Syrup

Despite a warning from the U.S. Food and Drug Administration that some of its Rompe Pecho cough syrup was contaminated and could…

Terry Turner April 17, 2020
Contaminated Mental Health Drug Recall Adds to Lamictal Risks

Taro Pharmaceuticals voluntarily recalled some of its Lamictal (lamotrigine) medication after tests showed some of the mental health…

Terry Turner April 17, 2020

1
2
3
4
5
6
7
8
9
…
68

Drugwatch Archives

Looking for an older news story? Search the Drugwatch archives for any of our published news posts by month and category.

Month

Category

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

© 2021 Drugwatch.com Privacy Policy /